These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25731213)

  • 1. Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses.
    Jentsch MC; Van Buel EM; Bosker FJ; Gladkevich AV; Klein HC; Oude Voshaar RC; Ruhé EG; Eisel UL; Schoevers RA
    Biomark Med; 2015; 9(3):277-97. PubMed ID: 25731213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in major depressive disorder: the role of mass spectrometry.
    Woods AG; Iosifescu DV; Darie CC
    Adv Exp Med Biol; 2014; 806():545-60. PubMed ID: 24952202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of serum biomarkers predicting development of a subsequent depressive episode in social anxiety disorder.
    Gottschalk MG; Cooper JD; Chan MK; Bot M; Penninx BW; Bahn S
    Brain Behav Immun; 2015 Aug; 48():123-31. PubMed ID: 25929723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics Approach for Biomarker Research in Major Depression: Antidepressant Effects.
    Huang TL; Lo LH
    Curr Drug Metab; 2018; 19(6):502-512. PubMed ID: 29623831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical markers subtyping major depressive disorder.
    Kunugi H; Hori H; Ogawa S
    Psychiatry Clin Neurosci; 2015 Oct; 69(10):597-608. PubMed ID: 25825158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments.
    Suseelan S; Pinna G
    Adv Clin Chem; 2023; 112():1-67. PubMed ID: 36642481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Mechanisms of Atypical and Melancholic Major Depressive Disorder.
    Tarasov VV; Ivanets NN; Svistunov AA; Chubarev VN; Kinkulkina MA; Tikhonova YG; Syzrantsev NS; Chubarev IV; Muresanu C; Somasundaram SG; Kirkland CE; Aliev G
    Curr Pharm Des; 2021 Oct; 27(31):3399-3412. PubMed ID: 34082674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seeking an objective diagnosis of depression.
    Bilello JA
    Biomark Med; 2016 Aug; 10(8):861-75. PubMed ID: 27415130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment and major depressive disorder in HIV infection and cerebrospinal fluid biomarkers.
    Almeida SM
    Arq Neuropsiquiatr; 2013 Sep; 71(9B):689-92. PubMed ID: 24141506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target-based biomarker selection - Mineralocorticoid receptor-related biomarkers and treatment outcome in major depression.
    Büttner M; Jezova D; Greene B; Konrad C; Kircher T; Murck H
    J Psychiatr Res; 2015; 66-67():24-37. PubMed ID: 25959615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel biomarkers in major depression.
    Schneider B; Prvulovic D
    Curr Opin Psychiatry; 2013 Jan; 26(1):47-53. PubMed ID: 23154643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Power laws in covariability of anxiety and depression among newly diagnosed patients with major depressive episode, panic disorder and controls.
    Katerndahl DA
    J Eval Clin Pract; 2009 Jun; 15(3):565-70. PubMed ID: 19522912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inflammatory cytokines: molecular biomarkers for major depressive disorder?
    Martin C; Tansey KE; Schalkwyk LC; Powell TR
    Biomark Med; 2015; 9(2):169-80. PubMed ID: 24524646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression subtyping based on evolutionary psychiatry: Proximate mechanisms and ultimate functions.
    Rantala MJ; Luoto S; Krams I; Karlsson H
    Brain Behav Immun; 2018 Mar; 69():603-617. PubMed ID: 29051086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder.
    Kahl KG; Rudolf S; Stoeckelhuber BM; Dibbelt L; Gehl HB; Markhof K; Hohagen F; Schweiger U
    Am J Psychiatry; 2005 Jan; 162(1):168-74. PubMed ID: 15625216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The promise of biomarkers in diagnosing major depression in primary care: the present and future.
    Redei EE; Mehta NS
    Curr Psychiatry Rep; 2015 Aug; 17(8):601. PubMed ID: 26081681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood biomarkers and treatment response in major depression.
    Mora C; Zonca V; Riva MA; Cattaneo A
    Expert Rev Mol Diagn; 2018 Jun; 18(6):513-529. PubMed ID: 29701114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding childhood depression.
    Malhotra S; Das PP
    Indian J Med Res; 2007 Feb; 125(2):115-28. PubMed ID: 17431280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of beta-endorphin in the pathophysiology of major depression.
    Hegadoren KM; O'Donnell T; Lanius R; Coupland NJ; Lacaze-Masmonteil N
    Neuropeptides; 2009 Oct; 43(5):341-53. PubMed ID: 19647870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.